{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:35:41Z","timestamp":1793907341151,"version":"4.8.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-03598-4","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T09:55:05Z","timestamp":1738058105000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Establishing of a risk prediction model for metabolic dysfunction-associated steatotic liver disease: a retrospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Nan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenbing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangfan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,28]]},"reference":[{"key":"3598_CR1","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1146\/annurev-pathol-012615-044224","volume":"11","author":"T Hardy","year":"2016","unstructured":"Hardy T, Oakley F, Anstee QM, Day CP. Nonalcoholic fatty liver disease: Pathogenesis and Disease Spectrum. Annual Rev Pathol May 23. 2016;11:451\u201396. https:\/\/doi.org\/10.1146\/annurev-pathol-012615-044224.","journal-title":"Annual Rev Pathol May 23"},{"issue":"17","key":"3598_CR2","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","volume":"21","author":"AJ Sanyal","year":"2021","unstructured":"Sanyal AJ, Van Natta ML, Clark J, et al. Prospective study of outcomes in adults with nonalcoholic fatty liver disease. New Engl J Med Oct. 2021;21(17):1559\u201369. https:\/\/doi.org\/10.1056\/NEJMoa2029349.","journal-title":"New Engl J Med Oct"},{"issue":"3","key":"3598_CR3","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1056\/NEJMc2118255","volume":"20","author":"P Horn","year":"2022","unstructured":"Horn P, Newsome PN. Nonalcoholic fatty liver disease. New Engl J Med Jan. 2022;20(3):294. https:\/\/doi.org\/10.1056\/NEJMc2118255.","journal-title":"New Engl J Med Jan"},{"issue":"6","key":"3598_CR4","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol Dec. 2023;79(6):1542\u201356. https:\/\/doi.org\/10.1016\/j.jhep.2023.06.003.","journal-title":"J Hepatol Dec"},{"issue":"1","key":"3598_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.7570\/jomes22021","volume":"30","author":"Y Huh","year":"2022","unstructured":"Huh Y, Cho YJ, Nam GE. Recent epidemiology and risk factors of nonalcoholic fatty liver disease. J Obes Metabolic Syndrome Mar. 2022;30(1):17\u201327. https:\/\/doi.org\/10.7570\/jomes22021.","journal-title":"J Obes Metabolic Syndrome Mar"},{"issue":"12","key":"3598_CR6","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1016\/j.cgh.2021.12.002","volume":"20","author":"MH Le","year":"2022","unstructured":"Le MH, Yeo YH, Li X, et al. 2019 global NAFLD prevalence: a systematic review and Meta-analysis. Clin Gastroenterol Hepatology: Official Clin Pract J Am Gastroenterological Association Dec. 2022;20(12):2809\u2013e281728. https:\/\/doi.org\/10.1016\/j.cgh.2021.12.002.","journal-title":"Clin Gastroenterol Hepatology: Official Clin Pract J Am Gastroenterological Association Dec"},{"issue":"1","key":"3598_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1055\/s-0044-1785196","volume":"44","author":"CM Canivet","year":"2024","unstructured":"Canivet CM, Boursier J, Loomba R. New nomenclature for nonalcoholic fatty liver disease: understanding metabolic dysfunction-Associated Steatotic Liver Disease, metabolic dysfunction- and Alcohol-Associated Liver Disease, and their implications in clinical practice. Seminars Liver Disease Feb. 2024;44(1):35\u201342. https:\/\/doi.org\/10.1055\/s-0044-1785196.","journal-title":"Seminars Liver Disease Feb"},{"issue":"4","key":"3598_CR8","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1111\/liv.15852","volume":"44","author":"ZM Younossi","year":"2024","unstructured":"Younossi ZM, Golabi P, Paik J, et al. Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa. Liver International: Official J Int Association Study Liver Apr. 2024;44(4):1061\u201370. https:\/\/doi.org\/10.1111\/liv.15852.","journal-title":"Liver International: Official J Int Association Study Liver Apr"},{"key":"3598_CR9","doi-asserted-by":"publisher","unstructured":"Nasiri-Ansari N, Androutsakos T, Flessa CM, et al. Endothelial cell dysfunction and nonalcoholic fatty liver Disease (NAFLD): a concise review. Cells Aug. 2022;12(16). https:\/\/doi.org\/10.3390\/cells11162511.","DOI":"10.3390\/cells11162511"},{"key":"3598_CR10","doi-asserted-by":"publisher","unstructured":"Velliou RI, Legaki AI, Nikolakopoulou P, Vlachogiannis NI, Chatzigeorgiou A. Liver endothelial cells in NAFLD and transition to NASH and HCC. Cellular and molecular life sciences: CMLS. Oct 5. 2023;80(11):314. https:\/\/doi.org\/10.1007\/s00018-023-04966-7","DOI":"10.1007\/s00018-023-04966-7"},{"issue":"5","key":"3598_CR11","doi-asserted-by":"publisher","first-page":"671","DOI":"10.21037\/hbsn-21-546","volume":"1","author":"X Yuan","year":"2023","unstructured":"Yuan X, Wang X, Wu S, et al. Associations between metabolic dysfunction-associated fatty liver disease and extrahepatic cancers: a cohort in China. Hepatobiliary Surg Nutr Oct. 2023;1(5):671\u201381. https:\/\/doi.org\/10.21037\/hbsn-21-546.","journal-title":"Hepatobiliary Surg Nutr Oct"},{"issue":"4","key":"3598_CR12","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/j.jtcvs.2017.12.107","volume":"155","author":"SY Park","year":"2018","unstructured":"Park SY, Nomogram. An analogue tool to deliver digital knowledge. J Thorac Cardiovasc Surg Apr. 2018;155(4):1793. https:\/\/doi.org\/10.1016\/j.jtcvs.2017.12.107.","journal-title":"J Thorac Cardiovasc Surg Apr"},{"issue":"1","key":"3598_CR13","doi-asserted-by":"publisher","first-page":"13877","DOI":"10.1038\/s41598-022-17511-6","volume":"16","author":"D Li","year":"2022","unstructured":"Li D, Zhang M, Wu S, Tan H, Li N. Risk factors and prediction model for nonalcoholic fatty liver disease in northwest China. Sci Rep Aug. 2022;16(1):13877. https:\/\/doi.org\/10.1038\/s41598-022-17511-6.","journal-title":"Sci Rep Aug"},{"issue":"S8","key":"3598_CR14","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1002\/cncr.35248","volume":"15","author":"Q Zheng","year":"2024","unstructured":"Zheng Q, Yan H, He Y, et al. An ultrasound-based nomogram for predicting axillary node pathologic complete response after neoadjuvant chemotherapy in breast cancer: modeling and external validation. Cancer Apr. 2024;15(S8):1513\u201323. https:\/\/doi.org\/10.1002\/cncr.35248.","journal-title":"Cancer Apr"},{"issue":"6","key":"3598_CR15","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/j.1440-1746.2007.05002.x","volume":"22","author":"GC Farrell","year":"2007","unstructured":"Farrell GC, Chitturi S, Lau GK, Sollano JD. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol Jun. 2007;22(6):775\u20137. https:\/\/doi.org\/10.1111\/j.1440-1746.2007.05002.x.","journal-title":"J Gastroenterol Hepatol Jun"},{"key":"3598_CR16","doi-asserted-by":"publisher","unstructured":"2016 Chinese guidelines for the management of dyslipidemia in adults. Journal of geriatric cardiology: JGC. Jan 2018;15(1):1\u201329. https:\/\/doi.org\/10.11909\/j.issn.1671-5411.2018.01.011","DOI":"10.11909\/j.issn.1671-5411.2018.01.011"},{"key":"3598_CR17","doi-asserted-by":"publisher","unstructured":"Chinese multi-disciplinary consensus on the diagnosis and treatment of hyperuricemia and its related diseases. Zhonghua nei ke za zhi. Mar 1 2017;56(3):235\u2013248. https:\/\/doi.org\/10.3760\/cma.j.issn.0578-1426.2017.03.021","DOI":"10.3760\/cma.j.issn.0578-1426.2017.03.021"},{"key":"3598_CR18","doi-asserted-by":"publisher","unstructured":"Ballestri S, Nascimbeni F, Baldelli E, Marrazzo A, Romagnoli D, Lonardo A. Jun. NAFLD as a sexual dimorphic disease: role of gender and Reproductive Status in the development and progression of nonalcoholic fatty liver disease and inherent Cardiovascular Risk. Advances in therapy. 2017;34(6):1291\u2013326. https:\/\/doi.org\/10.1007\/s12325-017-0556-1","DOI":"10.1007\/s12325-017-0556-1"},{"key":"3598_CR19","doi-asserted-by":"publisher","unstructured":"Kuwabara M, Hisatome I, Niwa K et al. Uric Acid Is a Strong Risk Marker for Developing Hypertension From Prehypertension: A 5-Year Japanese Cohort Study. Hypertension (Dallas, Tex: 1979). Jan 2018;71(1):78\u201386. https:\/\/doi.org\/10.1161\/hypertensionaha.117.10370","DOI":"10.1161\/hypertensionaha.117.10370"},{"issue":"2","key":"3598_CR20","doi-asserted-by":"publisher","first-page":"C584","DOI":"10.1152\/ajpcell.00600.2006","volume":"293","author":"YY Sautin","year":"2007","unstructured":"Sautin YY, Nakagawa T, Zharikov S, Johnson RJ. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative\/nitrosative stress. Am J Physiol Cell Physiol Aug. 2007;293(2):C584\u201396. https:\/\/doi.org\/10.1152\/ajpcell.00600.2006.","journal-title":"Am J Physiol Cell Physiol Aug"},{"issue":"1","key":"3598_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12916-017-0890-9","volume":"3","author":"T Bardin","year":"2017","unstructured":"Bardin T, Richette P. Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options. BMC Med Jul. 2017;3(1):123. https:\/\/doi.org\/10.1186\/s12916-017-0890-9.","journal-title":"BMC Med Jul"},{"issue":"5","key":"3598_CR22","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.jhep.2008.11.021","volume":"50","author":"Y Li","year":"2009","unstructured":"Li Y, Xu C, Yu C, Xu L, Miao M. Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study. J Hepatol May. 2009;50(5):1029\u201334. https:\/\/doi.org\/10.1016\/j.jhep.2008.11.021.","journal-title":"J Hepatol May"},{"issue":"6","key":"3598_CR23","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1111\/liv.13329","volume":"37","author":"K Wijarnpreecha","year":"2017","unstructured":"Wijarnpreecha K, Panjawatanan P, Lekuthai N, Thongprayoon C, Cheungpasitporn W, Ungprasert P. Hyperuricaemia and risk of nonalcoholic fatty liver disease: a meta-analysis. Liver International: Official J Int Association Study Liver Jun. 2017;37(6):906\u201318. https:\/\/doi.org\/10.1111\/liv.13329.","journal-title":"Liver International: Official J Int Association Study Liver Jun"},{"key":"3598_CR24","doi-asserted-by":"publisher","unstructured":"Li M, Gu L, Yang J, Lou Q. Jul. Serum uric acid to creatinine ratio correlates with \u03b2-cell function in type 2 diabetes. Diabetes\/metabolism research and reviews. 2018;34(5):e3001. https:\/\/doi.org\/10.1002\/dmrr.3001","DOI":"10.1002\/dmrr.3001"},{"issue":"12","key":"3598_CR25","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.dld.2010.04.005","volume":"42","author":"YJ Lee","year":"2010","unstructured":"Lee YJ, Lee HR, Shim JY, Moon BS, Lee JH, Kim JK. Relationship between white blood cell count and nonalcoholic fatty liver disease. Dig Liver Disease: Official J Italian Soc Gastroenterol Italian Association Study Liver Dec. 2010;42(12):888\u201394. https:\/\/doi.org\/10.1016\/j.dld.2010.04.005.","journal-title":"Dig Liver Disease: Official J Italian Soc Gastroenterol Italian Association Study Liver Dec"},{"issue":"6","key":"3598_CR26","doi-asserted-by":"publisher","first-page":"e010342","DOI":"10.1136\/bmjopen-2015-010342","volume":"6","author":"S Wang","year":"2016","unstructured":"Wang S, Zhang C, Zhang G, et al. Association between white blood cell count and non-alcoholic fatty liver disease in urban Han Chinese: a prospective cohort study. BMJ open Jun 1. 2016;6(6):e010342. https:\/\/doi.org\/10.1136\/bmjopen-2015-010342.","journal-title":"BMJ open Jun 1"},{"issue":"4","key":"3598_CR27","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.dsx.2014.09.002","volume":"8","author":"E Ryder","year":"2014","unstructured":"Ryder E, Diez-Ewald M, Mosquera J, et al. Association of obesity with leukocyte count in obese individuals without metabolic syndrome. Diabetes & metabolic syndrome. Oct-Dec. 2014;8(4):197\u2013204. https:\/\/doi.org\/10.1016\/j.dsx.2014.09.002.","journal-title":"Oct-Dec"},{"issue":"4","key":"3598_CR28","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1016\/j.jhep.2023.11.024","volume":"80","author":"J Chen","year":"2024","unstructured":"Chen J, Zhou H, Liu K. Normal weight and central obesity as predictors of increased all-cause mortality in metabolic dysfunction associated steatotic liver disease. J Hepatol Apr. 2024;80(4):e143\u20135. https:\/\/doi.org\/10.1016\/j.jhep.2023.11.024.","journal-title":"J Hepatol Apr"},{"key":"3598_CR29","doi-asserted-by":"publisher","first-page":"1244405","DOI":"10.3389\/fendo.2023.1244405","volume":"14","author":"G Semmler","year":"2023","unstructured":"Semmler G, Balcar L, Wernly S, et al. Insulin resistance and central obesity determine hepatic steatosis and explain cardiovascular risk in steatotic liver disease. Front Endocrinol. 2023;14:1244405. https:\/\/doi.org\/10.3389\/fendo.2023.1244405.","journal-title":"Front Endocrinol"},{"key":"3598_CR30","doi-asserted-by":"publisher","unstructured":"Wang J, Yan S, Cui Y, Chen F, Piao M, Cui W. The Diagnostic and Prognostic Value of the triglyceride-glucose Index in Metabolic Dysfunction-Associated fatty liver Disease (MAFLD): a systematic review and Meta-analysis. Nutrients Nov. 2022;23(23). https:\/\/doi.org\/10.3390\/nu14234969.","DOI":"10.3390\/nu14234969"},{"issue":"1","key":"3598_CR31","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1186\/s12967-022-03611-4","volume":"5","author":"H Hu","year":"2022","unstructured":"Hu H, Han Y, Cao C, He Y. The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population. J Translational Med Sep. 2022;5(1):398. https:\/\/doi.org\/10.1186\/s12967-022-03611-4.","journal-title":"J Translational Med Sep"},{"key":"3598_CR32","doi-asserted-by":"publisher","first-page":"4234061","DOI":"10.1155\/2016\/4234061","volume":"2016","author":"S Li","year":"2016","unstructured":"Li S, Hong M, Tan HY, Wang N, Feng Y. Insights into the role and interdependence of oxidative stress and inflammation in Liver diseases. Oxidative Med Cell Longev. 2016;2016:4234061. https:\/\/doi.org\/10.1155\/2016\/4234061.","journal-title":"Oxidative Med Cell Longev"},{"key":"3598_CR33","doi-asserted-by":"publisher","first-page":"9547613","DOI":"10.1155\/2018\/9547613","volume":"2018","author":"M Masarone","year":"2018","unstructured":"Masarone M, Rosato V, Dallio M, et al. Role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease. Oxidative Med Cell Longev. 2018;2018:9547613. https:\/\/doi.org\/10.1155\/2018\/9547613.","journal-title":"Oxidative Med Cell Longev"},{"issue":"5","key":"3598_CR34","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1053\/gast.2001.23256","volume":"120","author":"AJ Sanyal","year":"2001","unstructured":"Sanyal AJ, Campbell-Sargent C, Mirshahi F, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterol Apr. 2001;120(5):1183\u201392. https:\/\/doi.org\/10.1053\/gast.2001.23256.","journal-title":"Gastroenterol Apr"},{"issue":"3","key":"3598_CR35","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","volume":"146","author":"JE Lambert","year":"2014","unstructured":"Lambert JE, Ramos-Roman MA, Browning JD, Parks EJ. Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. Gastroenterol Mar. 2014;146(3):726\u201335. https:\/\/doi.org\/10.1053\/j.gastro.2013.11.049.","journal-title":"Gastroenterol Mar"},{"key":"3598_CR36","doi-asserted-by":"publisher","unstructured":"Reaven GM, Banting. lecture 1988. Role of insulin resistance in human disease. Diabetes. Dec 1988;37(12):1595\u2009\u2013\u2009607. https:\/\/doi.org\/10.2337\/diab.37.12.1595","DOI":"10.2337\/diab.37.12.1595"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03598-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-03598-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03598-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T21:42:16Z","timestamp":1738100536000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-03598-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,28]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3598"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-03598-4","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,28]]},"assertion":[{"value":"12 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study adhered to the Helsinki Declaration and was approved by the Ethics Committees of the First Affiliated Hospital of Zhejiang University School of Medicine (No. 2024\u2009\u2212\u20090369). Every participant in the study was anonymous, and it was retrospective in nature. Therefore, the Ethics Committees of the First Affiliated Hospital of Zhejiang University School of Medicine has waived informed consent for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}